Erin Squindo

** ***** ****** *** · Somerville, NJ 08876

Mobile: 732-***-**** · Email: ac8f7i@r.postjobfree.com

Summary of Qualifications

· Measure patient’s vital signs, weight and height.

· Prepare and administer medications as directed by the physician.

· Draw and collect patients’ blood and specimens for research purposes.

· Collect, prepare and log blood, tissue, and various other laboratory specimens.

· Design, develop, and maintain all research databases.

· Prepare patients for the physician and show them to the examination rooms.

· Explain a broad range of treatment procedures, medications, diets and physician’s instructions.

· Prepare patients’ blood and specimens for shipment, processing, and lab testing.

· Manage all aspects of patients’ documentation and the collection of medical information such as medical history, vital statistics, and test results.

· Develop, organize, and update test data database utilized for various research studies.

· Assist the Lab Director with a broad range of laboratory functions.

· Manage various administrative functions such as registering new patients, collecting copayments, updating patient demographics and scheduling appointments.

· Working with patient’s insurance companies to obtain prior authorization for medications and procedures.

Professional Experience

Rutgers-Department of Precertification 11/2015 – 09/2016

Precertification Nurse Coordinator for the Departments

of Cardiology, Hematology, Gastroenterology, Pulmonology

and Infectious Disease and Allergy

Rutgers University-Department of Neurology 09/2013 to 11/2016

Staff Nurse/ Study Coordinator

The Cardiovascular Institute of New Jersey 09/2010 to 09/2013

Staff Nurse/ Study Coordinator

Robert Wood Johnson Fitness and Wellness 02/2013 to 10/2014

Staff Nurse

The Mentor Network 09/2010 to 09/2011

House Nurse/health coordinator

Quest Diagnostic 11/2007 to 12/2008

Phlebotomist

Department of Neurology 05/2006 to 06/2008

Research Assistant

Princeton Medical Group 06/2004 to 09/2005

Medical Assistant/Phlebotomist

Nursefinders 06/2002 to 06/2004

Medical Assistant/Phlebotomist

Erin Squindo Resume, Page 2

Clinical Trials

CVT-301-004

A Phase 3, Randomized, Double-Blind, Placebo-Controlled

Study Investigating the Efficacy and Safety of CVT-301

(Levodopa Inhalation Powder) in Parkinson’s Disease Patients

With Motor Response Fluctuations (OFF Phenomena).

First HD

This study is being done to determine how well SD-809 ER or placebo lessens the abnormal movements (chorea) in people Huntington Disease (HD). The study will also look at the general safety and tolerability of slowly adjusting the dose of SD-809 ER or placebo.

ENROLL HD

This study is a worldwide observational study for Huntington’s disease families. The study monitors how the disease appears and changes over time in different people and is also open to people who either have HD or are at-risk.

National Institutes of Health Funding

Systolic Blood Pressure Intervention Trial (Sprint)

●A 2-arm, multicenter, randomized clinical trial designed to test whether a treatment program, aimed at reducing systolic blood pressure (SBP), will reduce cardiovascular disease (CVD) risk.

Industry Funding

Dual AntiPlatelet Therapy (DAPT)

●A prospective, multi-center, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy (DAPT) in subjects undergoing percutaneous coronary intervention (PCI) with either drug-eluting stent (DES) or bare metal stent (BMS) placement for the treatment of coronary artery lesions.

Sponsor: Harvard Clinical Research Institute

Elixa

●A randomized, double-blind, plecbo-controlled, parallel-group, multicenter study to evaluate cardiovascular outcomes during treatment with lixisenatide in type 2 diabetic patients after an Acute Coronary Syndrome event.

Sponsor: Sanofi Aventis

Alerts

●The ALERTS study is a Phase Two prospective, randomized multicenter study with FDA approval for 100 centers and 1020 subjects with a high-risk of having a heart attack. All subjects have data collection and analysis enabled from the onset, however, subjects are randomized 1:1 for patient alerting ON or OFF for the first 6 months. After the initial 6 month period, patient alerting is enabled for the control group.

Sponsor: AngelMed

IOP-116

●A Phase IV Pilot Study to Evaluate Kidney Damage Measured by Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a New Bio-Marker in Patients with Normal eGFR or Mild Renal Impairment Undergoing Coronary Angiography and/or Percutaneous Coronary Intervention with IOPAMIDOL Injection 370 or IODIXANOL 320.

Sponsor: Bracco

IOP-117

●A Phase IV Pilot Study to Evaluate Kidney Damage Measured by Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a New Bio-Marker in Patients with Moderate Fall in eGFR Undergoing Coronary Angiography and/or Percutaneous Coronary Intervention with IOPAMIDOL Injection 370 or IODIXANOL 320.

Sponsor: Bracco

Erin Squindo Resume, Page 4

IOP-118

●A Phase IV Pilot Study to Evaluate Kidney Damage Measured by Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a New Bio-Marker in Patients with Severe Fall in eGFR Undergoing Coronary Angiography and/or Percutaneous Coronary Intervention with IOPAMIDOL Injection 370 or IODIXANOL 320.

Sponsor: Bracco

Paradigm:

●A multicenter, randomized, double-blind, parallel group, active-controlled study to evaluate the efficiency and safety of LCZ696 compared to enalapril on morbidity and mortality in patients with chronic heart failure and reduced ejection fraction.

Sponsor: Novartis

Research Activities

UMDNJ – RWJMS, Study Coordinator

A Genetic Repository for the Study of Phenotype-Genotype Correlations in Parkinsonian Disorders.

National Institute of Health, Study Coordinator

Genetic linkage study in Parkinson’s disease.

Education, Licensure & Certification

Licensed Practical Nurse, New Jersey License # 26NP6445200

Middlesex County Vocational and Technical School Diploma in Practical Nursing, 6/2010

Medical Assistant/Phlebotomy Certification 11/1998

BLS for Healthcare Provider, 6/2015-6/2017

Universal First Aid, 6/2015-6/2017

CITI Course in the Protection of Human Research Subjects, 08/2017

Clinical Health and Safety Online Training, 08/2017

Blood borne Pathogens/Biosafety Training, 08/2017

EOHSS Shipping Training, 08/2017

HIPPA, UMDNJ, 08/2017

EMR Training 08/2015

EKG 12 Lead Training, 5/2010

Venipuncture Training, 5/2010

Contact this candidate